by Ryan Shatto | Apr 1, 2021 | Press Releases
Fiscal Year 2020 Highlights: Generated dramatic growth in total and pro forma revenue Released positive clinical data on its patented drug delivery technology and received new certifications at its research facility Acquired and expanded consumer wellness subsidiary...
by Ryan Shatto | Mar 16, 2021 | Press Releases
OXNARD, Calif. – CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched a new initiative for the clinical...
by Ryan Shatto | Mar 10, 2021 | Press Releases
OXNARD, Calif. – CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched two new clinical development programs...
by Ryan Shatto | Mar 3, 2021 | Press Releases
Sleep A.S.A.P. provides proof of concept and monetization for CURE’s patented oral thin-film technology LOS ANGELES & OXNARD, Calif. – CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology...
by Ryan Shatto | Feb 23, 2021 | Press Releases
OXNARD, Calif. – CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space,...